Publications . . Patents and Applications . .Conference Presentations

 

Patents and Applications (co-invented by our scientists):

1. Hu, S.; Tao, J.; Xie, J. “Process for Producing Atorvastatin, Pharmaceutically Acceptable Salts Thereof and Intermediates Thereof”, WO 2006134482.
2. Liu, J.; Nayyar, N.; Guo, M.; Wu, Z.; Borer, B. C.; Srirangam, A. N.; Mitchell, M. B.; Li, Y.; Chu, J.  “Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one as poly(ADP-ribose) polymerase inhibitor,” WO 2006033007.
3. Hu, S.; Martinez, C. A.; Tao, J.; Yazbeck, D. “An Efficient Microbial Preparation of Capravirine Metabolites M4 and M5”, US 20050043363.
4. Kung, P.-P.; Martinez, C.; Tao, J. “Enantioselective Biotransformations for Preparation of Protein Tyrosine Kinase Inhibitor Intermediates”, WO 2006021885.
5. Hu, S.; Tat, D.; Martinez, C. A.; Yazbeck, D.; Tao, J. “Methods for the Preparation of Stereoisomerically Enriched Amines”, WO 2005054186.
6. Hu, S.; Martinez, C. A; Tao, J. “An Efficient Method for the Production of Enantiopure Pregabalin”, US 2005283023.
7. Kucera, D.J.; Scott, R.W. “Compounds and process for the preparation of HIV protease inhibitors” US20040171842, 20040204591; US20050124673; WO 2005054187.
8. Notz, W. R. L.; Martinez, C. A “Convergent asymmetric synthesis route to produce a key intermediate towards the synthesis of a glycinamide ribonucleotide formyl transferase (GARFT) inhibitor.” WO 2004113328.
9. Dovalsantos, E. Z.; Flahive, E. J.; Halden, B. J.; Mitchell, M. B.; Notz, W. R. L.; Tian. Q. O’Neill-Slawecki, “Convergent synthesis of a glycinamide ribonucleotide formyltransferase (GARFT) inhibitor containing a methyl substituted thiophene core and a tetrahydropyrido[2,3-d]pyrimidine ring system and intermediates therefor.” WO 2004113337.
10. Devries, K.M.; Caron, S.; Hammen, P.D.; Taber, G.P.; Tucker, J.L.; Rose, P.R.; Post, R.J.; Raymer, B.K.  “Preparation of chiral carboxyphenylchromanols via saponification of the corresponding isopropyl esters”, US 2003158428.
11. Barbas III, C. F.; Cordova, A.; Notz, W. “Enantioselective methods for preparing a- and b-amino acid derivatives.” WO 200359915 .
12. DeVries, K.M.; Tucker J.L.; Couturier, M.; Andresen, B.M.; “Preparation of hydroxypyrrolidinyl ethylamine compounds useful as selective ?-opiod receptor agonists”, US 2002161241.
13. Tian, Q.; Nayyar, N.; Babu, S.; Tao, J.; Moran, T.; Dagnino, R.; Remarchuk, T.; Melnick, M.; Mitchell, L.; Bender, S. “Efficient Synthetic Routes for the Preparation of Rhinovirus Protease Inhibitors and Key Intermediates”, US 2002133020.
14. Damon, D.B.; Dugger, R.W.; Scott R.W. “Methods for Preparing 4-amino-1,2,3,4-tetrahydroquinoline-2-carboxylates,” WO 2002088069; WO 2002088085.
15. Tucker J.L.; Hammen, P.D.; Negri, J.T.; Mahon, K.P.; Lehner, R.S.; Wei, L.; Sklavounos, C.; “Process for preparing 4”-substituted-9-deoxo-9a-aza-9a-homoerythromycin A derivatives via epoxide ring cleavage/alkylamination for treating bacterial and protozoa infections”, EP 1253153.
16. Tucker J.L.; Colberg, J.; “Process and Ester Derivatives for Preparation of Cephalosporins”, WO 2002046199.
17. DeVries, Keith M.; Tucker, John L.; Hammen, Philip D.; Raymer, Brian K.; Rose, Peter R.; Caron, Stephane; Taber, Geraldine P.; Post, Ronald J.; “Processes for Preparing Chromanylbenzoic Acids”, WO 2002060888.
18. Tao, J.; Babu, S.; Dagnino, R.; Tian, R.; Remarchuk, T.; McGee, K.; Nayyar, N.; Moran, T. “Process for Preparation of Amidopentenoate Peptide Analog Rhinovirus Protease Inhibitors “, WO 2001014576.
19. Damon, D.B.; Dugger, R.W.; Scott, R.W. “Methods for preparing CETP inhibitors” and intermediates US 6600045; US 6689897; US 6706881.
20. Tian, Q.; Nayyar, N.; Babu, S.; Tao, J.; Moran, T.; Dagnino, R.; Remarchuk, T.; Melnick, M.; Mitchell, L.; Bender, S. “Synthetic Routes for the Preparation of Rhinovirus Protease Inhibitors and Key Intermediates”, WO 2001014329
21. Busse, J. K.; Zook, S. E.; Borer, B. C.  “Process for Preparing Oxazolines from Tetrahydrofurans,” WO 2001029013.
22. DeNinno, M.P.; Masamune, H.; Scott, R.W. “Preparation of Nucleosides as Adenosine Receptors, Antidiabetics, Enzyme Inhibitors, and for the Treatment of Ischemia,” WO 2001023399.
23. Scott, R.W. “Compound and process for producing b-Andrenergic Receptor Agonists” US 6297382; US 6441181.
24. Scott, R.W. “Process for the Synthesis of Nucleoside Analogs” US 6271370.
25. Hammen, P.D.; Rose, P.R.; Tucker, J.L.; DeVries, K.M.; Rescek, D.M.; “Purification of Carbazolemalonate Precursors of Carprofen”, US 6013808.
26. Hammen, P.D.; Rose, P.R.; Rescek, D.M.; Tucker, J.L.; DeVries, K.M.; “Purification of (6-Chloro-2-Carbazolyl) Methylmalonate Dialkyl Esters Using Acetic Acid.”, EP-965586.
27. Babu, S.; Borer, B. C.; Remarchuk, T. P.; Szendroi, R. J.; Whitten, K. R.; Busse, J.; Albizati, K. F.  “Methods of Making Intermediates for the Prepn. of the HIV-Protease Inhibitor Nelfinavir,” US 5925759.
28. Babu, S.; Borer, B. C.; Remarchuk, T. R.; Szendroi, R. J.; Whitten, K. R.; Busse, J. K.; Albizati, K. F.  “Preparation of Intermediates for the HIV-Protease Inhibitor Nelfinavir,” US 5705647.
29. Zhao, L.; Mathur, E. J.; Weiner, D.; Richardson, T.; Milan, A.; Burk, M. J.; Han, B.; Short, J. M. “Epoxide hydrolases, nucleic acids encoding them and methods for making and using them”, US 6943001; 6979733.
30. Sherman, D. H.; Liu, H-w.; Xue, Y.; Zhao, L. “DNA Encoding Methymycin and Pikromycin”, US 6265202
31. Abraham, T. W.; Cameron, D. C.; Hicks, P. M.; McFarlan, S. C.; Millis, J. R.; Rosazza, J.; Zhao, L.; Weiner, D. P. “Polypeptides and biosynthetic pathways for the production of monatin and its precursors ”, US 20050244937.
32. Abraham, T. W.; Cameron, D. C.; Goulson, M. J.; Hicks, P. M.; Lindley, M. G.; McFarlan, S. C.; Millis, J. R.; Rosazza, J.; Zhao, L.; Weiner, D. P. “Monatin tabletop sweetener compositions and methods of making same ”, US 20050112260.
33. Weiner, D. P.; Hitchman, T.; Zhao, L.; Burk, M. J.; Desantis, G.; Hanson, S.; Milan, A.; Richardson, T.; Kretz, P.; Greenberg, W. “Methods for the Manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes”, US 20030092033.
34. Sherman, D. H.; Liu, H-w.; Zhao, L. “Method to Alter Sugar Moieties”, US 20040160839.
35. Zhao, L.; Weiner, D. P.; Hickle, L. “Fumonisin detoxification enzyme gene isolated from environmental microorganisms, compositions and methods for making fumonisin-resistant transgenic plants, and detoxification for grains and foods and feeds.” WO 2004085624.